Structural basis for competitive inhibition of 3,4-dihydroxy-2-butanone-4-phosphate synthase from Vibrio cholerae.

The Journal of Biological Chemistry
Zeyaul IslamSubramanian Karthikeyan

Abstract

The riboflavin biosynthesis pathway has been shown to be essential in many pathogens and is absent in humans. Therefore, enzymes involved in riboflavin synthesis are considered as potential antibacterial drug targets. The enzyme 3,4-dihydroxy-2-butanone-4-phosphate synthase (DHBPS) catalyzes one of the two committed steps in the riboflavin pathway and converts d-ribulose 5-phosphate (Ru5P) to l-3,4-dihydroxy-2-butanone 4-phosphate and formate. Moreover, DHBPS is shown to be indispensable for Mycobacterium, Salmonella, and Helicobacter species. Despite the essentiality of this enzyme in bacteria, no inhibitor has been identified hitherto. Here, we describe kinetic and crystal structure characterization of DHBPS from Vibrio cholerae (vDHBPS) with a competitive inhibitor 4-phospho-d-erythronohydroxamic acid (4PEH) at 1.86-Å resolution. In addition, we also report the structural characterization of vDHBPS in its apo form and in complex with its substrate and substrate plus metal ions at 1.96-, 1.59-, and 2.04-Å resolution, respectively. Comparison of these crystal structures suggests that 4PEH inhibits the catalytic activity of DHBPS as it is unable to form a proposed intermediate that is crucial for DHBPS activity. Furthermore, vD...Continue Reading

References

Dec 15, 1975·European Journal of Biochemistry·C LazdunskiA Lazdunski
Jan 1, 1980·Methods in Enzymology·F Foor, G M Brown
Jul 14, 1995·The Journal of Biological Chemistry·K Kis, A Bacher
Jun 15, 1995·Structure·G J Kleywegt, T A Jones
Apr 2, 1996·Proceedings of the National Academy of Sciences of the United States of America·W J PhilippS T Cole
May 13, 1997·Proceedings of the National Academy of Sciences of the United States of America·P D AdamsA T Brünger
Jan 1, 1997·Methods in Enzymology·A BacherC Krieger
Dec 9, 2000·Analytical Biochemistry·M A PicollelliD B Jordan
Mar 10, 2001·Nature·S T ColeB G Barrell
Nov 1, 2001·Proceedings of the National Academy of Sciences of the United States of America·M J KellyH Oschkinat
Jul 27, 2002·Journal of Bacteriology·Svetlana Y GerdesAndrei L Osterman
Mar 27, 2003·Molecular Microbiology·Christopher M SassettiEric J Rubin
Aug 22, 2003·Protein Science : a Publication of the Protein Society·Katherine A Kantardjieff, Bernhard Rupp
Nov 18, 2004·Journal of Bacteriology·Nina R SalamaStanley Falkow
Dec 2, 2004·Acta Crystallographica. Section D, Biological Crystallography·Paul Emsley, Kevin Cowtan
Aug 24, 2005·The Journal of Biological Chemistry·Jingshan RenDavid K Stammers
Feb 24, 2006·Infection and Immunity·Claudia Rollenhagen, Dirk Bumann
Aug 8, 2007·Journal of Molecular Biology·Evgeny Krissinel, Kim Henrick
Feb 27, 2008·Archives of Biochemistry and Biophysics·Markus Fischer, Adelbert Bacher
May 6, 2008·Acta Crystallographica. Section D, Biological Crystallography·Thomas C TerwilligerLi-Wei Hung
Sep 25, 2008·BMC Microbiology·Susana FragoMilagros Medina
Aug 1, 2007·Journal of Applied Crystallography·Airlie J McCoyRandy J Read
Feb 4, 2010·Acta Crystallographica. Section D, Biological Crystallography·Wolfgang Kabsch
Feb 4, 2010·Acta Crystallographica. Section D, Biological Crystallography·Paul D AdamsPeter H Zwart
Feb 13, 2010·Chemical Biology & Drug Design·Quanxin LongJianping Xie
Apr 5, 2011·Acta Crystallographica. Section D, Biological Crystallography·Martyn D WinnKeith S Wilson
Apr 5, 2011·Acta Crystallographica. Section D, Biological Crystallography·Garib N MurshudovAlexei A Vagin
Oct 13, 2011·Molecular Systems Biology·Fabian SieversDesmond G Higgins

❮ Previous
Next ❯

Citations

Mar 30, 2018·The Journal of Biological Chemistry·Benoit JacquesJurgen Sygusch
Sep 11, 2019·Microbial Cell Factories·Sofía Hernandez-ArranzManuel Rodriguez-Concepcion

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.